|
The document outlines a protocol for a pharmacokinetic study of perfluorooctane sulfonyl fluoride (POSF) in male Sprague Dawley rats, sponsored by 3M, to assess its oral absorption, clearance, and metabolism to perfluorooctane sulfonate (PFOS) for risk characterization purposes.
|
1999 |
AR226-0209
|
1ywqr0EmbJB61dV7v5Q0NrkVm |
6 |
|
The document outlines a protocol for a pharmacokinetic study of perfluorooctane sulfonyl fluoride (POSF) in male Sprague Dawley rats, sponsored by 3M Specialty Chemicals Division, to assess its oral absorption, clearance, and metabolism to PFOS for risk characterization.
|
1999 |
AR226-0209
|
JNk1LOxmny2127E4LvjqxdLBe |
6 |